Home › Liver Diseases › Michigan › Ann Arbor
Liver Diseases clinical trials in Ann Arbor, MI
5 studies for Liver Diseases are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
Recruiting
- University of Michigan, Ann Arbor
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RecruitingPhase 1
- Clinical Trial Site, Ann Arbor
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Ann Arbor
- 89bio Clinical Study Site, Ypsilanti · 7 mi away
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Ypsilanti · 7 mi away
DILIN - Prospective Study
RecruitingObservational studyHealthy volunteers welcome
- University of Michigan, Ann Arbor
About Liver Diseases
Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.
More about Liver Diseases on MedlinePlus
Liver Diseases trials in other cities
- Houston, TX10 studies
- Chicago, IL9 studies
- Washington, DC8 studies
- Los Angeles, CA7 studies
- Atlanta, GA7 studies
- Philadelphia, PA6 studies
- Richmond, VA6 studies
- New York City, NY6 studies
- San Antonio, TX6 studies
- Durham, NC5 studies
- Dallas, TX5 studies
- Cincinnati, OH4 studies
Other studies in Ann Arbor
- Prostate Cancer26 studies
- Cancer (all types)25 studies
- Breast Cancer25 studies
- Lung Cancer23 studies
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease15 studies
- Pancreatic Cancer14 studies
- Multiple Myeloma13 studies
- Atrial Fibrillation12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.